SCHEMBL3303687

SCHEMBL3303687

CCN(CC)C(=O)c1ccc(S(=O)(=O)NC(=O)c2ccccc2OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.53
OPRD1 P41143 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.52
GAA P10253 2/20 0.51
ABL1 P00519 1/20 0.49
RIN1 Q13671 1/20 0.49
LIMK2 P53671 2/20 0.49
LIMK1 P53667 1/20 0.49
FLT1 P17948 1/20 0.49
FLT4 P35916 1/20 0.49
KDR P35968 1/20 0.49
RXFP1 Q9HBX9 1/20 0.48
KAT6A Q92794 1/20 0.48
LMNA P02545 2/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
CTSD P07339 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754035 0.87 GAA (0.54) GAAABL1RIN1LIMK2FLT1
SCHEMBL16634981 0.83 GAA (0.57) GAAFLT1FLT4KDRRXFP1
SCHEMBL26161946 0.82 GAA (0.56) GAAFLT1FLT4KDRRXFP1
SCHEMBL3302654 0.82 FLT1 (0.57) GAAFLT1FLT4KDRRXFP1
SCHEMBL18803129 0.82 POLB (0.64) L3MBTL1GAAFLT1FLT4KDR
SCHEMBL31249659 0.81 KDM4E (0.52) GAAFLT1FLT4KDRRXFP1
SCHEMBL9414560 0.81 POLB (0.68) L3MBTL1GAAFLT1FLT4KDR
SCHEMBL16244081 0.81 KDM4E (0.62) GAAFLT1FLT4KDRRXFP1
SCHEMBL125423 0.80 L3MBTL1 (0.54) L3MBTL1GAAFLT1FLT4KDR
SCHEMBL31249657 0.80 ALDH1A1 (0.50) GAAFLT1FLT4KDRRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2119699-B1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES BAYER IP GMBH (DE) 2016-09-21 EP disclosed
US-8236986-B2 Process for preparing acylsulfamoylbenzamides BAYER CROPSCIENCE GMBH (DE) 2012-08-07 US disclosed
US-20100094052-A1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES BAYER CROPSCIENCE GMBH (DE) 2010-04-15 US disclosed
EP-2119699-A1 Process for preparing acylsulfamoylbenzamides Bayer CropScience AG (DE) 2009-11-18 EP disclosed
US-7608736-B2 Chlorination a a benzenesulfamoyl compound in presence of a base BAYER CROPSCIENCE GMBH (DE) 2009-10-27 US disclosed
EP-1644324-B1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES BAYER CROPSCIENCE AG (DE) 2009-09-30 EP disclosed
EP-1644324-A1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES Bayer CropScience GmbH (DE) 2006-04-12 EP disclosed
US-20050004372-A1 Process for preparing acylsulfamoylbenzamides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-01-06 US disclosed
WO-2005000797-A1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES BAYER CROPSCIENCE GMBH (DE) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094052-A1 PROCESS FOR PREPARING ACYLSULFAMOYLBENZAMIDES SULT2A1, STS, SULT1A1 OPRM1 3676/4885OPRD1 4103/4885L3MBTL1 4598/4885
US-20050004372-A1 Process for preparing acylsulfamoylbenzamides SULT2A1, STS, SULT1A1 OPRM1 3676/4885OPRD1 4103/4885L3MBTL1 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.